ORA BIOMEDICAL, INC.

Tukwila, WA · Founded 2022 · Biotech · Private

Automated system for standardized C. elegans culture and lifespan measurement that controls environmental variables and records experimental metadata

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Headquarters: Tukwila, WA
Founded: 2022
Latest Form D: $720K, Jan 2024
Total capital: $1.3M

Federal grants: $399K; 2 awards · 2024; Rank in peer group#3 of 26
Private capital raised: $820K; 2 Form D · last Jan 2024; 33 months since last filing
Federal contracts: $75K; 1 award · Defense; Rank in Biotech#341 of 4373
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Aug 2024Federal grantHealth and Human S · Phase I · EleGantry: a software and hardware infrastructure to improve rigor and reproducibility within invertebrate research$324K
May 2024Federal grantDefense · Phase I · Identification Of Therapeutics To Improve Astronaut Health In Space$75K
May 2024Federal contractDefense · Identification Of Therapeutics To Improve Astronaut Health In Space$75K
Jan 2024Private capital raisedForm D · SEC · 2nd filing$720K
Jun 2022Private capital raisedForm D · SEC · 1st filing$100K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 26 peers

Line = median

Biotech · Instrument

Federal grants#3 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

John SabeyDirectorNamed in SEC Form D filings
Matthew KaeberleinDirector, PromoterNamed in SEC Form D filings
Mitchell LeeExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

AUM LIFETECH INCSimilar federal contract value in Biotech · $80K in contracts
PRIMETIME LIFE SCIENCES, LLCSimilar federal contract value in Biotech · $79K in contracts
Nexome Genomics Inc.Similar federal contract value in Biotech · $78K in contracts
Agios PharmaceuticalsSimilar federal contract value in Biotech · $73K in contracts
BIOLYTIC LAB PERFORMANCE, INC.Similar federal contract value in Biotech · $72K in contracts
ARDELYX, INC.Similar federal contract value in Biotech · $72K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.